Gerald E. Marti, MD, PhD, is a physician-scientist and hematologist with expertise in hematology, hematopathology, and clinical flow cytometry. He currently serves as a special volunteer and volunteer physician at the National Heart, Lung, and Blood Institute at the National Institutes of Health and as a volunteer clinical researcher with the Medicine Branch and Family Studies Section of the National Cancer Institute. He also works as an independent medical consultant and regulatory advisor. His clinical focus includes hematologic malignancies, immunophenotyping and laboratory diagnostics, and addiction medicine and public health. His research interests center on the biology of lymphoid neoplasms and precursor states, the standardization of clinical flow cytometry and cellular analysis, and prognostic biomarkers and targeted therapeutic approaches. Dr. Marti is widely recognized for landmark contributions to hematology, including the discovery and naming of Monoclonal B-cell Lymphocytosis, and for helping establish international standards in clinical flow cytometry. His honors include the NIH Clinical Center Award, the Wallace Coulter Foundation Award, a CDC award, and recognition as a Distinguished Lecturer by the International Clinical Cytometry Society. He has served as past president of the Maryland Chapter of the American Society of Addiction Medicine and has held leadership roles in international cytometry and hematology organizations. He earned his MD and PhD in Biochemistry from Northwestern University, completed his internal medicine residency at Northwestern University, and pursued fellowship training in hematology at the National Institutes of Health.
Medical Officer
Medical School
1968 – 1976
Residency
1977 – 1980
Fellowship
1980 – 1982